Berenberg Bank Keeps Their Buy Rating on AstraZeneca (AZN)
Berenberg Bank has reaffirmed its Buy rating on AstraZeneca (AZN) with a price target of £145.00, while the shares closed at £13,466.00. Analyst Luisa Hector, noted for her 4-star rating and 64.52% success rate, highlights a Moderate Buy consensus for AstraZeneca, with an average price target of £14,197.23, indicating a potential upside of 5.43%. Bernstein also maintains a Buy rating with a £180.00 target.
In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on AstraZeneca, with a price target of £145.00. The company’s shares closed yesterday at p13,466.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Hector is a 4-star analyst with an average return of 5.8% and a 64.52% success rate. Hector covers the Healthcare sector, focusing on stocks such as Sanofi, AstraZeneca, and Merck & Company.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a p14,197.23 average price target, implying a 5.43% upside from current levels. In a report released on November 10, Bernstein also maintained a Buy rating on the stock with a £180.00 price target.
